Member Info for wintzy

from an hour ago now being logged. Meaty 5 figure sums all over 72p.

Jarv. What's the connection between your antibody link and The Times article on vaccine production?

They're looking for volunteers....make yourself useful! You might get paid.

We get a mention in The Times:
"Tens of millions of pounds are being invested in production, which will be lost if the vaccine fails human trials that are expected to start in days. The biggest manufacturing plants will be in China and India but three UK companies are involved: Pall Biotech in Portsmouth, Cobra Biologics in Keele, Staffordshire, and Oxford Biomedica."

.94 paid

2 x big 15k volume buys.

Surprisingly all the evidence of studies in US and Germany is that non smokers are far more likely to end up in ICUs than smokers. The studies have baffled the scientists, basically smokers are overwhelmingly better protected. PHE comment was not based on science.

Good interview but he should have put a price on it. I know its not nice to talk about making profit from this, but it was the Business News. Should have said "it will be something like the home pregnancy test".

Good to see you back on board and look forward to your erudite comments.

Does he post on here these days? Would be interested in his assessment.

+22%. Not a great deal of volume.

Yes +13%.

So if you have the virus but no symptoms, this POC test will still show positive?

Hopefully keep a 10% increase.

OK Comek..my apologies.

45p? seems to have past that threshold at_home!

Last week article and it references the antibody tests. Avacta is assisting on antigen test.

50p being paid.

It was in Thursday's Times.
"John Dawson, 60, Oxford Biomedica’s chief executive, said that it had begun to prepare to manufacture the vaccine over the past week and “would expect to be producing batches this year”. The manufacturing will be accelerated if the vaccine is successful in the human trials and is approved by the Medicines and Healthcare products Regulatory Agency.

The financial terms of the arrangement were not disclosed. Mr Dawson said: “It is yet to be determined, but it won’t be on commercial rates. We won’t be making fortunes from it. We will work in the spirit of the community to try and get on top of this virus.”
Shares in Oxford Biomedica closed up 25.9 per cent, or 145p, at 705p."

Unfortunately, or fortunately, depending on your perspective, OXB has gone on record as saying it isn't looking to make money on its efforts, but add to the common cause. I noted that the share price stalled on that comment.